Skin damage among health care workers managing coronavirus disease-2019 - 14/04/20
Doi : 10.1016/j.jaad.2020.03.014
Jiajia Lan, MD a, b, Zexing Song, BS a, c, Xiaoping Miao, PhD d, Hang Li, MD, PhD e, Yan Li, MD, PhD a, b, Liyun Dong, MD a, b, Jing Yang, MD, PhD a, b, Xiangjie An, MD, PhD a, b, Yamin Zhang, MD, PhD a, b, Liu Yang, MD, PhD a, b, Nuoya Zhou, MD a, b, Liu Yang, BS a, f, Jun Li, MD, PhD g, JingJiang Cao, MD, PhD h, Jianxiu Wang, BS i, Juan Tao, MD, PhD a, b, ⁎ 
a Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
b Hubei Engineering Research Center for Skin Repair and Theranostics, Wuhan, China
c Second Clinical Medical College, Chongqing Medical University, Chongqing, China
d Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, China
e Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China
f Hunan Normal University School of Medicine, Changsha, China
g Department of Dermatology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
h Department of Dermatology, Renhe Hospital, Three Gorges University, Yichang, China
i Department of Dermatology, Xiangyang Hospital, Hubei University of Chinese Medicine, Xiangyang, China
∗Correspondence to: Juan Tao, MD, PhD, Department of Dermatology, Union Hospital, Tongji Medical College, No. 1277 Jiefang Ave, Wuhan, Hubei, 430022 ChinaDepartment of DermatologyUnion HospitalTongji Medical CollegeNo. 1277 Jiefang AveWuhanHubei430022China
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
| Dr Lan and Zexing Song contributed equally to this work. |
|
| Funding sources: This work was supported by HUST COVID-19 Rapid Response Call Program (2020kfyXGYJ056) and Hubei Provincial Emergency Science and Technology Program for COVID-19 (2020FCA037). |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Accepted for publication March 9, 2020. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 5
P. 1215-1216 - mai 2020 Retour au numéro
Article précédent
- Telehealth: Helping your patients and practice survive and thrive during the COVID-19 crisis with rapid quality implementation
- Ivy Lee, Carrie Kovarik, Trilokraj Tejasvi, Michelle Pizarro, Jules B. Lipoff
- Should biologics for psoriasis be interrupted in the era of COVID-19?
- Mark Lebwohl, Ryan Rivera-Oyola, Dedee F. Murrell
Bienvenue sur EM-consulte, la référence des professionnels de santé.